This guideline covers assessing and managing chronic hepatitis B in children, young people and adults. It aims to improve care for people with hepatitis B by specifying which tests and treatments to use for people of different ages and with different disease severities.
This guideline includes recommendations on:
- assessment and referral in primary care
- assessment of liver disease in secondary specialist care
- antiviral treatment
- surveillance testing for hepatocellular carcinoma in adults
Who is it for?
- Healthcare professionals
- Commissioners and providers
- People with chronic hepatitis B and their families and carers
Bermingham SL, Hughes R, Fenu E, Sawyer LM, Boxall E, Kennedy T et al. Cost-effectiveness analysis of alternative antiviral strategies for the treatment of HBeAg-positive and HBeAg-negative chronic hepatitis B in the United Kingdom. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2015; 18(6):800-809
Sarri G, Westby M, Kelsey A, Ritchie G, Hill-Cawthorne G, Thomas H. Chronic hepatitis B in children, young people and adults: summary of the new NICE guideline. Viral hepatitis in practice. 2013; 5(2):4-7
Sarri G, Westby M, Bermingham S, Hill-Cawthorne G, Thomas H. Diagnosis and management of chronic hepatitis B in children, young people, and adults: summary of NICE guidance. BMJ. 2013; 346:f3893
Sarri G, Ritchie G, Hill-Cawthorne G. Identification, testing, and support are key in chronic hepatitis B. Guidelines in Practice. 2013; 16(11)